TD Asset Management
ADPT icon

TD Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

TD Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
82,186
+51,516
+168% +$789K ﹤0.01% 996
2026
Q1 		$426K Buy
+30,670
New +$489K ﹤0.01% 1180
2023
Q4 		– Sell
-31,494
Closed -$172K – 1389
2023
Q3 		$172K Sell
31,494
-33,491
-52% -$221K ﹤0.01% 1377
2023
Q2 		$436K Sell
64,985
-6,500
-9% -$48.3K ﹤0.01% 1294
2023
Q1 		$631K Sell
71,485
-19,634
-22% -$173K ﹤0.01% 1221
2022
Q4 		$696K Hold
91,119
– – ﹤0.01% 1217
2022
Q3 		$624K Hold
91,119
– – ﹤0.01% 1255
2022
Q2 		$737K Hold
91,119
– – ﹤0.01% 1232
2022
Q1 		$1.26M Sell
91,119
-88,953
-49% -$1.4M ﹤0.01% 1194
2021
Q4 		$5.05M Buy
180,072
+60,100
+50% +$1.84M ﹤0.01% 870
2021
Q3 		$4.08M Buy
119,972
+5,900
+5% +$213K ﹤0.01% 871
2021
Q2 		$4.18M Buy
114,072
+13,697
+14% +$532K ﹤0.01% 877
2021
Q1 		$4.04M Buy
100,375
+35,719
+55% +$1.93M ﹤0.01% 889
2020
Q4 		$3.82M Buy
64,656
+18,200
+39% +$938K ﹤0.01% 869
2020
Q3 		$2.26M Hold
46,456
– – ﹤0.01% 876
2020
Q2 		$2.25M Buy
46,456
+1,100
+2% +$40.1K ﹤0.01% 848
2020
Q1 		$1.26M Buy
45,356
+18,524
+69% +$517K ﹤0.01% 942
2019
Q4 		$803K Buy
26,832
+1,700
+7% +$48.8K ﹤0.01% 1146
2019
Q3 		$777K Buy
+25,132
New +$1.03M ﹤0.01% 1103

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TD Asset Management's ADPT Position: Q2 2026 in Review

TD Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 168% in Q2 2026, buying an estimated $789K and bringing the position to 82,186 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #996.

TD Asset Management first reported a position in ADPT in Q3 2019 and has held it in 19 quarters since. The position peaked at $5.05M in Q4 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • TD Asset Management held 82,186 shares of Adaptive Biotechnologies worth $1.76M as of Q2 2026.
  • TD Asset Management bought 51,516 Adaptive Biotechnologies shares in Q2 2026, an estimated $789K.
  • Adaptive Biotechnologies made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #996 holding.
  • TD Asset Management first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 19 quarters since.
  • TD Asset Management's Adaptive Biotechnologies position peaked at $5.05M in Q4 2021.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.